Order Article Reprints

Amr AE-GE, Mageid REA, El-Naggar M, M. Naglah A, S. Nossier E, Elsayed EA. Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A. Molecules. 2020; 25(5):1096. https://doi.org/10.3390/molecules25051096

Amr, Abd El-Galil E., Randa E. Abdel Mageid, Mohamed El-Naggar, Ahmed M. Naglah, Eman S. Nossier, and Elsayed A. Elsayed. 2020. "Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A" Molecules 25, no. 5: 1096. https://doi.org/10.3390/molecules25051096

Amr, A. E.-G. E., Mageid, R. E. A., El-Naggar, M., M. Naglah, A., S. Nossier, E., & Elsayed, E. A. (2020). Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A. Molecules, 25(5), 1096. https://doi.org/10.3390/molecules25051096